Food scientists study link between pathogens and illness



If you’re committed to fitness, the decision to climb a couple of flights of stairs rather than take the elevator is clear. But if you develop chest pain on the way up, deciding how to treat the symptoms of clogged arteries in your heart is much more complicated. Whether it’s appropriate to treat chest pain

Full Post: Appropriate use criteria for coronary revascularization

No food processor wants pathogens contaminating the product in the plant for at least one obvious reason; the product on sale at retail might carry the risk of foodborne illness.

Beyond that, it isn’t clear what are the chances that a consumer will become ill.

Helen Jensen and colleagues are seeking to connect the dots to determine how changes in the pork production process affect the predicted number of people who become ill with salmonellosis because of pork and how food safety interventions affect risk as well as industry costs. By learning that information, the meat industry would be able to figure the costs of intervening at points in the production process that would be the most effective in making the product safer.

“We think this model will be helpful for the industry whether it’s the packing plant or the Pork Board,” said Jensen, an Iowa State University professor of economics. She has collaborated with Scott Hurd, an associate professor of veterinary diagnostic and production animal medicine who is spending most of 2008 on leave from ISU as deputy undersecretary for food safety at the U.S. Department of Agriculture. They are pursuing the research with support from the Food Safety Consortium.

Jensen said in discussing the subject with the pork industry, the key question has been whether to invest resources in the farm or in the slaughterhouse. “Then if we do invest resources in the slaughterhouse or on the farm, what’s the gain we’re going to get? Gain in this situation is measured by reduction in the number of human cases of illness,” she said.

It’s unusual to carry the research all the way to measuring the number of human illnesses. Jensen noted that U.S. research has not explored that angle to the extent that Europeans have done. Data are limited on Salmonella in the United States for anyone seeking to find out about its seroprevalence - the number of persons who test positive for a disease stemming from the bacterium.

“We’re mostly depending on one study done here at Iowa State which has found that the really large swine farms have a somewhat higher seroprevalence than everybody else,” Jensen said. “Now we’re converting our data by size categories so that we can put them into our model and say, ‘If that’s true for the whole the whole U.S. and we apply those data across all herds in the U.S., how is that going to work out as far as the number of contaminated carcasses?’” The epidemiological model is being integrated with a multi-market economic model that evaluates producer and processor behavior and the economic effect on the pork industry.

One significant question to follow is what interventions can be made during the production process that will have an effect on curbing human illness. It isn’t an easy matter to resolve.

“There’s a tendency to think that there’s a nice linear relationship - every reduction of Salmonella on the pig farm is going to reduce human health risk by the same portion. And that’s just not true, for a number of reasons,” Jensen said.

Hurd analyzed data from Denmark, which has kept more extensive records of the cause-and-effect situation than has the United States. In Denmark, the data show that pathogen reduction on the farm had little impact on human health risk. But pathogen reduction in the slaughterhouse did make a difference.

“The Danish study showed the most cost effective place to invest resources was in the slaughterhouse, because you get a better return on your investment when return is measured in terms of human health cases,” Jensen explained. “How many human cases of Salmonella can we reduce per dollar invested?”

http://www.uark.edu/

Link



--------------------------------------------------------------------------------------------
Related Posts:


A food scare in Britain involving pork from Ireland has forced all major supermarkets to remove all Irish pork products from their shelves because of concerns they may contain toxic dioxins. Britain’s Food Standards Agency (FSA) says tests on pork sourced from the Irish Republic or Northern Ireland have revealed the possible contamination with potentially

Full Post: Dioxins in Irish pork causes food scare in Britain



While consumers in the U.S. seem to be grappling to deal with an almost continuous parade of food recalls and alerts, Australian consumers will be heartened to hear that since 2000 the number of Australian food recalls has fallen to its lowest level in 8 years. According to food regulator, Food Standards Australia New

Full Post: Most Australian food recalls due to ‘foreign matter’



Food and Drug Administration (FDA) officials in the United States have confirmed the presence of salmonella in a popular snack made by food giant Kellogg. The FDA says salmonella was found in a package of peanut butter sandwich crackers made by Kellogg as the company issued a precautionary recall across the food industry. The suspect

Full Post: Salmonella prompts recall of Kellogg’s snacks



If a case of avian flu is discovered in a U.S. poultry flock, it’s likely that poultry consumption would decline. The level of decline would also be likely to vary in different parts of the nation. Kansas State University surveyed 2,000 people by mail in Wichita, Kan., and Los Angeles - 1,000 in each city

Full Post: If avian flu hits poultry consumption could decline



The Cure Our Children Foundation, a nonprofit charitable foundation dedicated to children, announced today that the U.S. Food and Drug Administration (FDA) has approved the Orphan Drug Designation of the foundation’s unique drug product for children with Ewing’s Sarcoma cancer. The efforts to develop this drug were made possible by the generous volunteers and researchers

Full Post: FDA grants orphan drug status to new ‘Trojan Horse’ like Ewing’s Sarcoma drug --------------------------------------------------------------------------------------------